Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 23490334)

1.

Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).

Biglia N, Maggiorotto F, Liberale V, Bounous VE, Sgro LG, Pecchio S, D'Alonzo M, Ponzone R.

Eur J Surg Oncol. 2013 May;39(5):455-60. doi: 10.1016/j.ejso.2013.02.007. Epub 2013 Mar 13.

PMID:
23490334
2.

Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.

Warneke J, Berger R, Johnson C, Stea D, Villar H.

Am J Surg. 1996 Nov;172(5):496-500.

PMID:
8942552
4.

Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma.

Wanis ML, Wong JA, Rodriguez S, Wong JM, Jabo B, Ashok A, Lum SS, Solomon NL, Reeves ME, Garberoglio CA, Senthil M.

Am Surg. 2013 Oct;79(10):1119-22.

PMID:
24160812
5.

Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma.

Horvath JW, Barnett GE, Jimenez RE, Young DC, Povoski SP.

World J Surg Oncol. 2009 Mar 24;7:34. doi: 10.1186/1477-7819-7-34.

6.

Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.

Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e547-51. doi: 10.1016/j.ijrobp.2011.04.050. Epub 2011 Jun 2.

PMID:
21640491
7.

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.

Cocquyt VF, Blondeel PN, Depypere HT, Praet MM, Schelfhout VR, Silva OE, Hurley J, Serreyn RF, Daems KK, Van Belle SJ.

Eur J Surg Oncol. 2003 May;29(4):361-7.

PMID:
12711290
8.

Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.

Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, Cortese G, Farina M, Vitelli C.

Ann Surg Oncol. 2012 Apr;19(4):1107-14. doi: 10.1245/s10434-011-1907-9. Epub 2011 Sep 13.

PMID:
21913022
9.

Clear margins for invasive lobular carcinoma: a surgical challenge.

Sakr RA, Poulet B, Kaufman GJ, Nos C, Clough KB.

Eur J Surg Oncol. 2011 Apr;37(4):350-6. doi: 10.1016/j.ejso.2011.01.010. Epub 2011 Feb 1.

PMID:
21277728
10.

[Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].

Paumier A, Sagan C, Campion L, Fiche M, Andrieux N, Dravet F, Pioud R, Classe JM.

J Gynecol Obstet Biol Reprod (Paris). 2003 Oct;32(6):529-34. French.

11.

The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.

Topps A, Clay V, Absar M, Howe M, Lim Y, Johnson R, Bundred N.

Eur J Surg Oncol. 2014 Jul;40(7):813-7. doi: 10.1016/j.ejso.2014.03.026. Epub 2014 Apr 4.

PMID:
24797703
12.

Preliminary results: double lumpectomies for multicentric breast carcinoma.

Kapoor NS, Chung A, Huynh K, Giuliano AE.

Am Surg. 2012 Dec;78(12):1345-8.

PMID:
23265123
13.

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.

Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E; I-SPY TRIAL Investigators.

Breast Cancer Res Treat. 2012 Nov;136(1):35-43. doi: 10.1007/s10549-012-2233-z. Epub 2012 Sep 8.

PMID:
22961065
14.

Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.

Sharma SD, Barry M, O'Reilly EA, Kell MR.

Eur J Surg Oncol. 2015 Jan;41(1):79-85. doi: 10.1016/j.ejso.2014.09.004. Epub 2014 Oct 2.

PMID:
25441933
15.

The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.

Jung SY, Jeong J, Shin SH, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J.

BMC Cancer. 2010 Dec 3;10:664. doi: 10.1186/1471-2407-10-664.

16.

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Arpino G, Bardou VJ, Clark GM, Elledge RM.

Breast Cancer Res. 2004;6(3):R149-56. Epub 2004 Feb 17.

17.

Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes.

Wasif N, Maggard MA, Ko CY, Giuliano AE.

Ann Surg Oncol. 2010 Jul;17(7):1862-9. doi: 10.1245/s10434-010-0953-z. Epub 2010 Feb 17.

PMID:
20162457
18.

Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.

Wazer DE, Schmidt-Ullrich RK, Ruthazer R, Schmid CH, Graham R, Safaii H, Rothschild J, McGrath J, Erban JK.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):851-8.

PMID:
9531370
19.

Is invasive lobular carcinoma different from invasive ductal carcinoma?

Mersin H, Yildirim E, Gülben K, Berberoğlu U.

Eur J Surg Oncol. 2003 May;29(4):390-5.

PMID:
12711296
20.

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.

Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas CH, Hortobagyi GN, Rouzier R, Esteva FJ, Pusztai L.

Br J Cancer. 2013 Feb 5;108(2):285-91. doi: 10.1038/bjc.2012.557. Epub 2013 Jan 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk